Literature DB >> 31075813

Introducing the New COPD Pocket Consultant Guide App: Can A Digital Approach Improve Care? A Statement of the COPD Foundation.

Byron Thomashow1, James D Crapo2, M Bradley Drummond3, MeiLan K Han4, Ravi Kalhan5, Elisha Malanga6, Vinny Malanga6, David M Mannino7, Stephen Rennard8, Frank C Sciurba9, Kristen S Willard6, Robert Wise10, Barbara Yawn6.   

Abstract

The COPD Foundation has tried to address gaps in chronic obstructive pulmonary disease (COPD) care by providing COPD Pocket Consultant Guide cards to U.S. health care providers. Since launching the card in 2007, there have been numerous updates and more than 800,000 of these cards have been distributed at no charge to health care professionals. The most recent versions have concentrated on presenting an algorithm for COPD management based on 7 severity domains: spirometry, symptoms, exacerbations, oxygen requirements, the presence of chronic bronchitis or emphysema and comorbidities. To increase the usability and reach of this tool, the COPD Pocket Consultant Guide is now available as an app for iOS and Android. This updated version of the app includes new COPD and asthma/COPD overlap flow charts; an interactive therapy chart that takes into account modified Medical Research Council (mMRC), COPD Assessment Test (CAT), and spirometry scores; anxiety and depression screeners; up-to-date medication charts in both brand and generic formats; a checklist to aid in determining when a patient should be referred to a pulmonologist and more. Potential use of the COPD Pocket Consultant Guide app in clinical care is discussed. JCOPDF
© 2019.

Entities:  

Keywords:  AECOPD; Pocket Consultant Guide; acute exacerbation of COPD; anxiety; app; chronic obstructive pulmonary disease; copd; depression; exacerbations; maintenance; management; medication

Year:  2019        PMID: 31075813      PMCID: PMC6872221          DOI: 10.15326/jcopdf.6.3.2018.0167

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  23 in total

1.  Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial.

Authors:  Valerie G Press; Vineet M Arora; Lisa M Shah; Stephanie L Lewis; Jeffery Charbeneau; Edward T Naureckas; Jerry A Krishnan
Journal:  J Gen Intern Med       Date:  2012-05-17       Impact factor: 5.128

Review 2.  The 2017 Update to the COPD Foundation COPD Pocket Consultant Guide.

Authors:  Barbara Bp Yawn; Byron Thomashaw; David M Mannino; MeiLan K Han; Ravi Kalhan; Stephen Rennard; Scott Cerrata; James D Crapo; Robert Wise
Journal:  Chronic Obstr Pulm Dis       Date:  2017-07-15

Review 3.  The Asthma-COPD Overlap Syndrome.

Authors:  Dirkje S Postma; Klaus F Rabe
Journal:  N Engl J Med       Date:  2015-09-24       Impact factor: 91.245

4.  The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease.

Authors:  John Steer; John Gibson; Stephen C Bourke
Journal:  Thorax       Date:  2012-08-15       Impact factor: 9.139

5.  Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.

Authors:  David A Lipson; Frank Barnhart; Noushin Brealey; Jean Brooks; Gerard J Criner; Nicola C Day; Mark T Dransfield; David M G Halpin; MeiLan K Han; C Elaine Jones; Sally Kilbride; Peter Lange; David A Lomas; Fernando J Martinez; Dave Singh; Maggie Tabberer; Robert A Wise; Steven J Pascoe
Journal:  N Engl J Med       Date:  2018-04-18       Impact factor: 91.245

6.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

7.  Indacaterol-Glycopyrronium versus Salmeterol-Fluticasone for COPD.

Authors:  Jadwiga A Wedzicha; Donald Banerji; Kenneth R Chapman; Jørgen Vestbo; Nicolas Roche; R Timothy Ayers; Chau Thach; Robert Fogel; Francesco Patalano; Claus F Vogelmeier
Journal:  N Engl J Med       Date:  2016-05-15       Impact factor: 91.245

8.  Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.

Authors:  Kenneth R Chapman; John R Hurst; Stefan-Marian Frent; Michael Larbig; Robert Fogel; Tadhg Guerin; Donald Banerji; Francesco Patalano; Pankaj Goyal; Pascal Pfister; Konstantinos Kostikas; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2018-08-01       Impact factor: 21.405

9.  Withdrawal of inhaled glucocorticoids and exacerbations of COPD.

Authors:  Helgo Magnussen; Bernd Disse; Roberto Rodriguez-Roisin; Anne Kirsten; Henrik Watz; Kay Tetzlaff; Lesley Towse; Helen Finnigan; Ronald Dahl; Marc Decramer; Pascal Chanez; Emiel F M Wouters; Peter M A Calverley
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

Review 10.  Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Michael E Wechsler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-17
View more
  3 in total

1.  Clinical Development and Research Applications of the Chronic Obstructive Pulmonary Disease Assessment Test.

Authors:  Hana Müllerová; Mark T Dransfield; Byron Thomashow; Paul W Jones; Stephen Rennard; Niklas Karlsson; Malin Fageras; Norbert Metzdorf; Stefano Petruzzelli; Jean Rommes; Frank C Sciurba; Maggie Tabberer; Debora Merrill; Ruth Tal-Singer
Journal:  Am J Respir Crit Care Med       Date:  2020-05-01       Impact factor: 21.405

2.  New Adopters of Telemedicine During the Coronavirus-19 Pandemic in Respondents to an Online Community Survey: The Case for Access to Remote Management Tools for Individuals with Chronic Obstructive Pulmonary Disease.

Authors:  Danielle M Boyce; Byron M Thomashow; Jamie Sullivan; Ruth Tal-Singer
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27

3.  Does Evaluation and Management of COPD Follow Therapeutic Strategy Recommendations?

Authors:  Fernando J Martinez; Byron Thomashow; Tamar Sapir; Laura Simone; Jeffrey Carter; MeiLan Han
Journal:  Chronic Obstr Pulm Dis       Date:  2021-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.